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Abstract
Meprins, metalloproteases that are highly expressed in the brush-border membranes of
kidney proximal tubules, have been associated with ischemia-reperfusion induced kidney injury.
Osteosarcoma 9 (OS9), a peripheral membrane protein, has been shown to selectively interact
with the carboxyl-terminal tail of meprin beta (β). Additionally, OS9 was shown to promote
oxygen-dependent degradation of the hypoxia-inducible factor 1α (HIF1α), a protein involved in
oxygen homeostasis. However, it is not known if OS9 is a meprin substrate. The objective of
this study was to determine if OS9 is a meprin substrate, and whether there is a correlation
between expression of meprins, OS9, and HIF1α under hypoxic conditions.
To determine if meprins are capable of degrading OS9, purified human OS9 was coincubated with activated recombinant forms of meprin A and B. Our results show that meprin B
cleaves/degradation OS9. This was not observed for meprin A, suggesting isoform-specific
cleavage. Mardin-Darby canine kidney (MDCK) cells and human embryonic kidney 293 cells
transfected with meprin α or β cDNA were depleted of oxygen by exposure to 125 µM cobalt
chloride. Non-transfected cells served as controls. Western blot analysis was used to evaluate
the nuclear fraction levels of OS9 and HIF1α. Our data showed that HIF-1α stabilized in the
nucleus in a time-dependent manner and the levels of OS9 increased in non-transfected controls
cells depleted of oxygen. To our knowledge, this is the first study to identify OS9 as a meprin B
substrate. The degradation of OS9 by meprin B could impact the hypoxic response in kidney
cells.
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CHAPTER 1
Introduction
1.1 Life’s Requirement for Oxygen and Energy
Cells utilize oxygen for energy production in the form of adenosine-5´-triphosphate
(ATP) to carry out cellular functions. During oxidative phosphorylation, oxygen serves as an
electron acceptor in the formation of ATP. An adequate supply of oxygen is essential for cells to
perform their functions and for cells to survive. Cells must try to compensate under low levels of
oxygen known as hypoxia. If a cell is unable to compensate, or if there is an abrupt lack of
oxygen, then it can lead to cell death.

In vitro models have been developed and to study the

effects of hypoxia and ATP-depletion in cells. These methods include using pharmacological
agents to induce hypoxia and ATP-depletion in cultured.
1.2 Ischemia-Reperfusion Injury
An organ may experience ischemia (restriction of blood supply) by an event such as
physical blockage, organ transplantation, or diabetic chronic kidney failure. The organ is starved
of oxygen and nutrients until blood flow restoration occur. The sudden rush of blood, containing
oxygen and other nutrients, creates a catastrophic event within the organ resulting in tissue
damage or disease. The damage resulting from the return of blood after a period of ischemia is
termed ischemia-reperfusion injury. Ischemia results in oxygen- and ATP-depletion both of
which have been shown to disrupt the cell cytoskeleton and its associated membrane structures
(Ongeri, Anyanwu, Reeves, & Bond, 2011). The damage caused to cells under hypoxia and the
inability to produce ATP is of great significance. Research is required to understand the
pathogenesis of disease to organs that have experienced ischemia-reperfusion injury.
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1.3 Meprins and Osteosarcoma 9
Meprins are metalloproteases that are highly expressed in the brush-border membranes of
kidney proximal tubules. Meprins are capable of degrading extracellular matrix proteins, and
processing certain bioactive peptides. Changes in the level of expression and localization of
meprins have been associated with the pathology of ischemia-reperfusion induced kidney injury
in mice and rats (Bylander et al., 2008; Carmago, Shah, & Walker, 2002; Trachtman,
Valderrama, Dietrich, & Bond, 1995; Walker, Kaushal, & Shah, 1998). Recent research has
identified two cytoskeletal proteins, actin and villin, as meprin substrates (Ongeri et al., 2011).
Osteosarcoma 9 (OS9) is a protein associated with the cytoplasmic side of the
endoplasmic reticulum. OS9 plays a role in the endoplasmic reticulum (ER) associated
degradation pathway, and binds to the key regulator of cellular hypoxic response known as
hypoxia-inducible factor 1 (HIF1). In 2002, the research of Litovchick et al. showed that OS9
interacts specifically with the intracellular region of meprin B. However, it is not known
whether OS9 is a meprin substrate. Beak et al. (2005) demonstrated that OS9 is a negative
regulator of HIF-1α. To date, no research has provided a correlation between the expression
levels of OS9 and the master regulator of homeostasis gene of HIF1α.
1.4 Objectives and Impact
The objective of the current research was to determine if OS9 is a meprin substrate and
investigate the mechanism(s) by which meprins enhance damage to the kidney, using an in vitro
kidney cell model. The central hypothesis is that OS9 is a substrate of meprin. A second
objective was to evaluate how meprins impact the expression of OS9 and the hypoxia response
gene HIF-1α.
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Meprins have been associated with damage and disease to the kidneys during ischemia
reperfusion and diabetic chronic kidney failure.

The identification of meprin substrates and its

role in the hypoxia response would be useful in the development of treatments for patients
undergoing kidney transplants. Stopping this process or reducing the rate of the enzyme would
minimize organ damage which occurs in the process of ischemia-reperfusion injury.
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CHAPTER 2
Literature Review
2.1 Ischemia-Reperfusion
Periods of time may exist when blood flow is cut off from an organ; thus, oxygen and
nutrients can no longer be delivered to the organ. The shortage of blood supply is termed
ischemia, and hypoxia occurs during ischemia. Reperfusion is when blood flow is restored after
a period of deficient blood flow. Situations which could lead to (ischemia-reperfusion (IR)
include immobility, stroke, heart attack, organ transplantation, transfusion, physical blockage,
and diabetic chronic kidney failure. The lack of oxygen and nutrients from blood during the
ischemic period creates a condition in which the restoration of circulation results in inflammation
and oxidative damage through the induction of oxidative stress rather than restoration of normal
function. Ischemic injury is the leading cause of acute kidney disease (Gunaratnam &
Bonventre, 2009). Five percent of hospital patients are inflicted with ischemic acute tubular
necrosis with a mortality rate of 50% (Ympa, Sakr, Reinhart, & Vincent, 2005). Studies show
that the pars recta (SC segment) of proximal tubules is the most susceptible to injury (Heyman,
Shina, Brezis, & Rosen, 2002; Lieberthal & Nigam, 1998). Chronic hypoxia leads to end stage
renal disease. The important effector of tubular cell injury during prolonged hypoxia is ATPdepletion (Devarajan, 2006). Reperfusion injury develops hours or days after the influx event
(Kosieradzki & Rowinski, 2008). The sudden rush of flow back into the organ causes a cascade
of events. A disruption in the cytoskeleton leads to loss of brush-border, a breakdown of cell
junctions, and the incorrect relocalization of sodium-potassium ATPases from the basal surface
to the apical surface (Gunaratnam & Bonventre, 2009). Newly freed intracellular molecules of
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calcium activate proteases and phospholipases. This reperfusion event is the causative agent of
oxidative injury to tubular cells (Bonventre & Zuk, 2004).
Ischemic diseases of the kidney lead to an imbalance of vasoactive substances and
vasoconstrictors. The accumulation of vasoconstrictors initiates pro-inflammatory and
chemotactic cytokines that begins the up-regulation of adhesion molecules. Leukocytes adhere
within the site and release cytotoxic cytokines, reactive oxygen species, and proteolytic enzymes
resulting in even more damage to the tubular cells (Bonventre & Zuk, 2004). Cells will attempt
to recover from the ischemia-induced damage by repairing/regenerating themselves via
undergoing processes of apoptosis, autophagy, and/or necrosis (Kosieradzki & Rowinski, 2008).
The extent of damage to the organ depends on whether more cells die or if more cells are able to
regenerate.
2.2 Meprins
Meprins are zinc metalloproteases that are highly expressed in the brush-border
membranes (BBM) of kidney proximal tubules. Meprins belong to the astacin family (J. S. Bond
& Beynon, 1995; Johnson & Bond, 1998). Meprins are also found in the skin, pancreas, testis,
regions of the brain, liver, heart, and leukocytes (Becker-Pauly et al., 2007; Crisman, Zhang,
Norman, & Bond, 2004; Huguenin et al., 2008; Kenny & Ingram, 1987; Molitoris, Dahl, &
Geerdes, 1992). Meprins are capable of degrading extracellular matrix proteins such as collagen
and fibronectin (Kaushal, Walker, & Shah, 1994; Walker et al., 1998), and processing bioactive
proteins such as neurotension and gastrin (Chestukhin, Muradov, Litovchick, & Shaltiel, 1996;
Sterchi, Naim, Lentze, Hauri, & Fransen, 1988). Meprins are the only known endopeptidase in
the BBM that degrades proteins: others either only degrade small polypeptides, or are
exopeptidases (J. S. Bond, and Jiang, W., 1997). Five percent of the total protein found in BBM
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is meprin with expression being localized to the apical membrane of proximal tubule S3 cells
(Craig, Reckelhoff, & Bond, 1987). Meprins were identified as the major matrix-degrading
enzymes in rat renal tubules (Kaushal et al., 1994; Walker, Kaushal, & Shah, 1994).
The proteolytic enzymatic activity of meprins makes them essential components of
cellular activities. Due to their destructive potential, meprins must be highly regulated.
Regulation is accomplished through zymogen formation, inhibition, localization to specific
compartments, and transcriptional regulation (Bertenshaw, Norcum, & Bond, 2003). Meprins
contain a signal peptide that directs the protein to the lumen of the endoplasmic reticulum (ER)
during synthesis, and a propeptide that inhibits activity (Johnson & Bond, 1997). The structure
of meprins consists of two subunits, α and β (Johnson & Hersh, 1992). The subunits are 42%
identical at the amino acid level, highly glycosylated, and form disulfide-linked homo- or
heterodimers (J. S. Bond & Beynon, 1995; Marchand, Tang, & Bond, 1994). Each subunit has
astacin-like catalytic domain with several protein-interaction domains (Tsukuba & Bond, 1998).
Meprin A is a homooligomer of α-subunits or a heterooligomer of α/β subunits, while meprin B
is a homooligomer of β-subunits (Johnson & Bond, 1998). Although both forms of meprins
prefer substrates containing at least 6 amino acids (Butler & Bond, 1988), meprin A selects
amino acids that are small and hydrophobic within the P1´ site and prefers proline residues in P2´
site, while meprin B is predominantly an ASP/Glu-N peptidase with a preference towards acidic
residues within the P1´site (Bertenshaw et al., 2001). These differences can account for the
diverse functions of the 2 meprin isoforms.
The research of Bertenshaw (2003) provided information on the structure of meprins.
Meprin α-subunits associates into larger multimers while meprin B does not form mass
complexes of higher levels. Dimers of α/β only form tetramers. The latent form of
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homooligomer meprin A forms even larger complexes to the activated form. The degree of
multimerization has been deemed to be dependent upon the protein and salt concentration.
The location where meprin is found depends upon the subunit. Meprins containing at
least one β-subunit remain membrane-bound due to the transmembrane domain located near the
carboxyl terminus of the β-subunit (J. S. Bond & Beynon, 1995). Membrane-bound forms of
kidney meprin have been found to be concentrated in the juxtamedullary region of cortex (Craig
et al., 1987), and it was determined that meprin β-subunits in the mouse kidney are primary in
the latent, proenzyme form (Butler & Bond, 1988). Meprin A is secreted while mouse meprin B
and heterooligomer A are membrane-bound. Homooligomer A is able to be freed from the
membrane due to a 56 amino acid inserted domain that permits the proteolytic event during
maturation (Tang & Bond, 1998).
2.3 Meprins and Ischemia-Reperfusion Induced Renal Injury
One of the functions of the kidney is to provide clearance of plasma polypeptides
(Cuber, Bernard, Gibard, & Chayvialle, 1989). Chronic renal failure patients have higher levels
of peptides involved in gut mortality. Meprins play a role in the catabolism of extracellular
matrix (ECM) proteins. The potential exist where the absence of meprins may account for some
of the accumulation of ECM proteins that leads to fibrosis resulting in ESRD (Bertenshaw et al.,
2003). Knowledge on the role(s) of meprins in ischemia-reperfusion induced injury is growing.
Changes in the level of expression and localization of the meprin β-subunit have been associated
with the pathology of ischemia-reperfusion-induced kidney injury in mice and rats (Bylander et
al., 2008; Carmago et al., 2002; Trachtman et al., 1995; Walker et al., 1998). It has been
proposed that in IR-induced acute renal injury, depletion of oxygen and ATP results in
accumulation of intracellular sodium, calcium, and reactive oxygen species. These changes are
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believed to activate various enzyme systems including proteases, resulting in disruption of the
BBM cytoskeleton and membrane damage, subsequently leading to necrosis and apoptosis
(Molitoris, Leiser, & Wagner, 1997). Meprin is cytotoxic, and may play a role in IR injury
(Carmago et al., 2002). The latent homooligomer form of meprin A is not a toxic agent in IR
(Bylander et al., 2008), suggesting that activation occurs in IR.
Studies with mouse models have increased our knowledge of the influence of meprins in
IR-induced renal damage. In 1995, Trachtman el al. showed that non-congenic mice strains with
lower renal meprin levels developed less renal injury following IR. In contrast, strains of mice
with higher levels of the heterooligomer meprin A (α/β) had more severe IR damage when
compared to strains that express meprin B only (Bylander et al., 2008). In meprin B knockout
mice there is less disruption and shedding in proximal tubule cell membranes, reduced
inflammatory response, and an overall better preservation of kidney function after IR (Bylander
et al., 2008). In wild-type mice, kidney meprin B and homooligomeric meprin A are latent due
to their prosequences that inhibit proteolytic activity (Butler & Bond, 1988; Villa, Bertenshaw,
Bylander, & Bond, 2003). The prosequence is removed, via an unknown mechanism, in
membrane-bound meprin A. Bylander et al., (2008) propose that the activated membrane-bound
meprin A is the most likely damaging factor in vivo after IR.
2.4 Osteosarcoma 9
Research has shown that meprins cause damage to the kidney subjected to ischemiareperfusion injury. The identity of meprin substrates will help in understanding the mechanisms
by which damage is occurring within the kidney. Osteosarcoma 9 has been shown to interact
with the C terminal tail of meprin β, and this interaction may provide a mechanism by which
meprins modulate the hypoxia response. OS9 plays a role in the Endoplasmic reticulum (ER)-
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associated degradation pathway. Proteins that fail to fold or assemble with partnered subunits
are selectively removed from the endoplasmic reticulum (ER) via ER-associated degradation
pathway (ERAD). Proteins selected for the ERAD pathway are polyubiquitinated and relocated
into the cytosol for proteasome degradation (Romisch, 2005). Studies have shown that
osteosarcoma amplified 9, endoplasmic reticulum lectin (OS9) are upregulated in response to ER
stress, and OS9 is associated with ERAD machinery and ERAD substrates (Alcock & Swanton,
2009). With the use of RNAi, OS9 was proven to be required for efficient ubquitination of
glycosylated ERAD substrates. OS9 aided in the transfer of misfolded proteins (Alcock &
Swanton, 2009). Osteosarcoma amplified 9, endoplasmic reticulum lectin is a protein coding
gene (GenBank ID: 10956) located on 12q13 chromosome of humans that is overly expressed in
osteosarcomas (Su, Hutter, Trent, & Meltzer, 1996). OS9 is known to bind to HIF, and promote
degradation of one of its subunits (Baek et al., 2005) . The analysis of OS9’s cDNA sequence
revealed 2785 bp with an open reading frame of 667 amino acids residues (Su et al., 1996). Su et
al. determined that the OS9 gene encoded a 2.8 kB mRNA transcribed in all of the tissue samples
examined; therefore, OS9 is ubiquitously expressed in human tissues.
2.5 Interaction Between Meprin β and OS9
OS9 is a peripheral membrane protein associated with the cytoplasmic side of the ER,
and OS9 may be involved in ER-Golgi transport of meprin B (Litovchick, Friedmann, &
Shaltiel, 2002). Meprin A undergoes proteolysis in the ER resulting in the removal of its short
carboxyl-terminal cytoplasmic tail (Johnson & Hersh, 1992). Litovchick et al. published work in
2002 (Litovchick et al.) with the purpose of identifying proteins that interact with tail maintained
by meprin B, and to deduce the role of the tail. Litovchick earlier in 1998 found that the
cytoplasmic domain of rat meprin B is indispensable for its ER-to-Golgi transport, and removal
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results in entrapment of meprin B in ER (Litovchick, Chestukhin, & Shaltiel, 1998).
Litovchick’s research in 2002 demonstrated that OS9 interacts specifically with the intracellular
region of meprin B. OS9 is a peripheral membrane protein associated with the cytoplasmic side
of the ER, and OS9 may be involved in ER-Golgi transport of meprin B. Non-spliced OS9
binds to the tail of meprin B. The 674Thr-Ala689 region of meprin B is critical for the binding of
OS9 (Litovchick et al., 2002). This same region is also required for ER-Golgi transport.
Litovchick proposes that OS9 interaction with the tail may occur during maturation in ER. In
addition, immunofluorescence and fractionation showed that OS9 cell distribution is similar to
some ER chaperones.
2.6 Hypoxia Response Genes
A cell survives and thrives under normoxic (normal oxygen) conditions. When the levels
of oxygen drop, then the cell is able to sense the difference in the oxygen level. The cell can
alter its energy metabolism using anaerobic glycolysis to produce ATP, but this is only a shortterm solution. The cell must respond to this environmental stimulus in order to maintain
regulation, and for long-termed survival. Hypoxia induces genes to supply oxygen; with
hypoxia inducible factor 1 (HIF-1) controlling the expression of most of these genes (Semenza,
1998). A hypoxia inducible factor (HIF) is the cellular response to hypoxia. HIF is the master
regulator of hypoxia-response genes (Myllyharju & Schipani, 2010), and HIF-1 functions as a
master regulator of oxygen homeostasis that mediates changes in gene transcription in response
to changes in cellular oxygen levels (Baek et al., 2005). An alternate means of ATP production
is achieved by providing an oxygen-independent mechanism modulated by HIF-1 (Baek et al.,
2005). HIF-1 is required for transcriptional activation mediated by the erythropoietin gene
enhancer in hypoxic cells (Semenza, 1994). Experimentation performed by Wang (1995)
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evaluated the levels of protein and RNA in cells exposed to 1% oxygen for a predetermined time
period before oxygen was replenished back to 20%. The RNA and protein levels rapidly
decayed which confirms HIF-1’s role as a mediator of transcriptional response to hypoxia. The
structure of HIF-1 consists of a heterodimer composed of 1 of 3 α-subunits (HIF-1α-2α-or-3α)
and a β-subunit (Ema et al., 1997; Gu, Moran, Hogenesch, Wartman, & Bradfield, 1998; Tian,
McKnight, & Russell, 1997; Wang & Semenza, 1995). HIF-1β is constitutively located within
the nucleus (Berchner-Pfannschmidt et al., 2004). HIF-1 (alpha and beta) are basic-helix-loophelix-PAS proteins with expression being regulated by cellular oxygen tension (Wang, Jiang,
Rue, & Semenza, 1995). The proteolytic stability and transcriptional activity of HIF-1α -and
HIF-2α is regulated by two separate oxygen-dependent hydroxylation events (Myllyharju &
Schipani, 2010). Under normoxia, little to no HIFα is detectable in the nucleus. HIFα contains
an oxygen-depended degradation domain where two –Leu-X-X-Leu-Ala-Pro- sequences are
hydroxylated during normal conditions by HIF prolyl 4-hdroxylase (HIF-P4H) (Bruick &
McKnight, 2001; Epstein et al., 2001; Ivan et al., 2001). The 4-hydroxyproline residues formed
by the HIF-P4Hs are required for the binding to von Hippel-Lindau E3 ubiquitin complex
(Myllyharju & Schipani, 2010). This process is known as the ubiquitin proteasome pathway
where HIF1α is constitutively synthesized, but destroyed when normoxic conditions exist
(Berchner-Pfannschmidt et al., 2004; Kallio, Wilson, O'Brien, Makino, & Poellinger, 1999;
Salceda & Caro, 1997). HIFα is degraded by the 26S proteasome (Huang, Gu, Schau, & Bunn,
1998). The dependency of oxygen, during the binding of the von-Hippel-Lindau protein (pVHL)
(Maxwell et al., 1999), depends on post-translational hydroxylation of HIF1α at proline residues
564 and 402 by prolyl hydroxylases (Epstein et al., 2001; Ivan et al., 2001). Oxygen is required
for the activity carried out by prolyl hydroxylases.
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When hypoxic conditions arise, prolyl hydroxylation ceases, HIFα is not recognized by
the pVHL and therefore evades degradation (Berchner-Pfannschmidt et al., 2004). Consequently
HIFα dimerizes with HIFβ , and is then translocated to the nucleus where it is bound to the HIF
responsive elements (Myllyharju & Schipani, 2010). Formed active complexes turn on
expression of target genes including vascular endothelial growth factor (VEGF), erythropoietin,
glucose transporter-1, and carbonic anhydrase (Bracken, Whitelaw, & Peet, 2003; Wenger,
2002).
Beak et al. (2005) demonstrated the role of OS9 as a regulator of HIF1. OS9 interacts
with HIF1α to promote oxygen-dependent degradation of HIF-1α by the proteasome. Beak’s
research showed OS9 as a negative regulator of HIF1 that promotes prolyl hydroxylation by
interacting with HIF-1α and PHDs. A complex is formed with HIF1α, OS9, and PHD2 or
PHD3. OS9 PHD2 binds separately to HIF-1α at non-overlapping sites. OS9 promotes the
interaction of HIF-1α with PDH leading to hydroxylation followed by proteasomal degradation.
While OS9 has been shown to interact with OS9, it’s not known if OS9 is a meprin substrate and
how meprin cleavage of OS9 would impact the hypoxia response.
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CHAPTER 3
Materials and Methods
3.1 Reagent Inventory
The following antibodies were purchased from Abcam, Cambridge, MA: anti-GAPDH
mouse monoclonal antibody, and anti-HIF1α rabbit polyclonal antibody. Minimum essential
medium eagle were purchased from the American type culture collection ATCC (Manassas,
VA). The following supplies were purchased from Bio-Rad Laboratories, Hercules, CA: 30%
acrylamide (29:1 bis solution), anti-mouse IgG secondary antibody, anti-rabbit IgG secondary
antibody, and Bio-Rad protein assay reagent. A biotinylated protein ladder was purchased from
Cell Signaling Technology (Danvers, MA). Dr. Judith Bond of the Pennsylvania State
University College of Medicine (Hershey, PA) donated anti-meprin-A rabbit polyclonal antibody
(HMC14) and anti-meprin-B mouse polyclonal antibody (HMC77). The following chemicals
were purchased from Fisher Scientific (Pittsburgh, PA): ammonium persulfate, dithiothreitol,
ethylenediaminetetraacetic acid, protein markers , glycerol, glycine, hydrochloric acid,
hydroxyethyl piperazineethanesulfonic acid, isobutyl alcohol, magnesium chloride, methanol,
nonfat powdered milk, phosphate buffered saline, potassium chloride, sodium vanadate, Tris,
Tris base, trypsin, tween 20, and β-mercaptoethanol. Antibiotic-antimycotic and fetal bovine
serum were purchased from Hyclone Laboratories (Logan, UT). Dulbecco’s minimum essential
medium was purchased from Life Technologies (Grand Island, NY). Anti-OS9 rabbit polyclonal
antibody and purified human OS9 protein were purchased from OriGene Technologies
(Rockville, MD). The following chemicals were purchased from Sigma-Aldrich, St. Louis, MO:
actinonin, antimycin A, bromophenol blue, cobalt II chloride hexahydrate, sodium bicarbonate,
sodium chloride, sodium dodecyl sulfate, tetramethylethylenediamine, tris (2-carboxyethyl)
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phosphine hydrochloride, triton X-100, and 2-deoxy-D-glucose. The following chemicals were
purchased from Thermo Scientific, Waltham, MA: ethyl alcohol 200 proof (Acros Organics),
100X ethylenediaminetetraacetic acid solution, 100X halt protease inhibitor cocktail, and
Supersignal West Pico Chemiluminescent substrate.
3.2 Cell Culture
Human Embryonic Kidney 293 (HEK 293) cells were purchased from American Type
Culture Collection (Manassas, Virginia) with the addition of meprin transfected cells gifted from
the laboratory of Dr Judith Bond (Penn State College of Medicine, Hershey, PA). Cells were
propagated in minimum essential medium eagle supplemented with 10% FBS and antibiotics,
subcultured, and preserved in liquid nitrogen. The cell cultures were incubated at 37°C and 5%
CO2 for the duration of the growth cycle. The cell cultures were observed on the second day
using an inverted microscope. The cell cultures were observed daily to monitor the confluency
of the cells. The cell cultures were replaced with new complete growth media weekly. The
cells were grown to a confluency rate of at least 80% before being harvested.
3.3 Oxygen Depletion
Oxygen depletion was induced in the HEK 293 cells using Cobalt (II) Chloride. Cells
were allowed to grow to 80% confluency in Eagle’s MEM medium with 10% FBS. The media
was changed to a serum-free medium containing 0.1% BSA overnight. The cell cultures were
exposed to 125 µM cobalt chloride (Sigma, St. Louis, MO) for pre-determined time intervals of
0 min, 30 min, 1 hr, 2 hr, and 3 hr.
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3.4 ATP Depletion
A combination of 2-deoxy-D-glucose and antimycin A was used to induce ATP depletion
in the HEK 293 cells. The cells were washed 2-3 times with warm, sterile-filtered PBS media.
The cell culture medium was replaced with Dulbecco’s PBS “ATP-depletion medium” (Life
Technologies, Grand Island, NY) containing 1.5 mM CaCl2, 2 mM MgCl2, 2 mM deoxy-Dglucose, and 10 µM antimycin A for 0 hr, 30 min, 1 hr, and 2 hr.
3.5 Protein Extraction
A hypotonic buffer, a high salt buffer, and RIPA buffer were used for fractionation of
proteins from the cultured cells. The hypotonic buffer consisted of 10 mM Hepes (pH 7.9), 1.5
mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM Na3VO4, and protease inhibitor/EDTA. The high
salt buffer was prepared by combining the following: 20 mM Hepes (pH 7.9), 420 mM NaCl,
1.5 mM MgCl2, 0.5 mM DTT, 1 mM Na3VO4, 25% glycerol, and protease inhibitor/EDTA. The
RIPA buffer was prepared by combining 0.02 mM Hepes pH7.9, 0.015 mM NaCl, 0.1 mM
Triton-X 100, 0.01 mM SDS, 1 mM Na3VO4, and protease inhibitor cocktail/EDTA. Cells were
rinsed with ice cold PBS twice. The last wash was aspirated completely. Three-hundred µl of
hypotonic buffer was added to each 100 mm dish. The dishes were allowed to sit on ice for 30
minutes, and swirled every 10 minutes. The cells were harvested using a cell scrapper. The
lysate was transferred to a microfuge tube, and centrifuged at 4° C for 10 minutes at a speed of
15,000 x g. The supernatant was transferred to a new tube, and labeled as the cytoplasmic
extract. Fifty µl of high salt buffer was added to the pellet, and the pellet was resuspended in the
solution. This was placed on ice for 20 minutes, and centrifuged once again 4° C for 10 minutes
at a speed of 15,000 x g. The supernatant was transferred to a new tube and labeled as the
nuclear-enriched extract. The pellet was resuspended in 100 µl of RIPA buffer, and allowed to
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sit on ice for 20 minutes. The microfuge tube was centrifuged 4° C for 10 minutes at a speed of
15,000 x g. The supernatant was transferred to a new tube labeled as membrane-enriched
fraction. All fractions were kept on ice if protein quantification was to be immediately
performed, or frozen at -20° C until a later date when the protein quantification was to be
performed.
3.6 Determination of Protein Concentration
The concentrations of proteins obtained from the protein extraction were determined
using Bio-Rad’s protein assay reagent (Hercules, CA). This assay is based upon the Bradford
method. The prepared samples were allowed to sit at room temperature for 10 minutes before
having their optical densities read on VIS light at 595. Microsoft spreadsheet was utilized in
order to plot the standard curve. The estimated protein concentrations were derived from the
standard curve.
3.7 Electrophoretic Separation of Proteins by SDS-PAGE
Proteins were separated by electrophoresis on 10% polyacrylamide gels. Equal amounts
of proteins ranging from 40-60 µg were loaded in each well. Five µl EZ-Run Pre-Stained Rec
Protein LadderTM (Fisher Scientific, Pittsburgh, PA) was loaded into the first well and used for
tracking protein migration. The amounts required of each were obtained from using a preformed excel template. The samples were boiled in SDS sample buffer with β mercaptoethanol
for 5 minutes before loading. The gels were run at 200 V for roughly 45 min or until the
migration front had reached the bottom of the gel.
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3.8 Western Blot Analysis
The polyacrylamide gel containing the separated proteins was positioned on
nitrocellulose membrane that was presoaked in transfer buffer (250 nM Tris, 192 nM Glycine,
and 20% Methanol), and embedded between two thick, pieces of soaked filter paper. The unit
was fully assembled, and allowed to transfer at 15 V for one hour. The membrane was incubated
in 8% milk in Tris-buffered saline with 0.1% Tween-20 (TBS-T) for one hour at room
temperature to block non-specific binding sites. The membrane was incubated in primary
antibody with gentle agitation at room temperature for one hour, or overnight at 4° C. The
membrane was then washed with TBS-T three times for 10 minutes per cycle at room
temperature on a shaker. The secondary antibody was added using the same procedure with the
exception that the secondary antibody is added in TBS-T in lieu of milk. The membrane
underwent its final wash with TBS-T with three cycles at 15 minutes each.
The Western blots were developed using Chemiluminescent Substrates (Thermo
Scientific, Waltham, MA). The film was processed using the X-ray developer. The quantitation
of the protein bands was performed using Bio-Rad’s GS-800 calibrated densitometer along with
QuantityOne software.
3.9 Confirmation of Meprin B Expression by Meprin β cDNA Transfected Cells
In order to assess the interaction of meprin with OS9, and HIF1α, it was necessary to
verify the presence of meprins within the transfected cells. Using Western blot analysis, meprin
B was detected in the cytosolic and membrane-enriched fraction (Figure 1). Furthermore, the
detection of meprin within the cytosolic fraction provides evidence that OS9 and meprin can be
found within close proximity to one another within the cell.
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3.10 Determination of OS9 Cellular Localization
Western blot analysis were performed on all three cell genotypes HEK 293 cells to
determine the cellular localization for OS9. OS9 was strongly detected in the nuclear fraction
for all of the cell proteins. Faint bands were also detected within the cytosolic fraction. This
information provided the basis for only using the nuclear fraction for carrying out the Western
immunoblots when investigating OS9.
3.11 Determining If Meprins Degrade OS9
To determine if meprins are capable of cleaving OS9, purified activated forms of meprin
A and meprin B (4 nM) were co-incubated with purified OS9 (92 nM) in buffer consisting of 20
mM Tris and 150 mM NaCl, pH 7.5. Control reactions were incubated in buffer without
meprins. Equal volumes of proteins were taken from the reaction mixture at 0, 0.5, 1, 2, 3, and 4
hours. The reaction was stopped by addition of SDS buffer and boiling for 5 minutes. The
samples were loaded onto 10% polyacrylamide gels and separated by electrophoresis as
described above, followed by Western blot analysis with anti-OS9 antibodies.
3.12 Determining Whether Degradation of OS9 Is Meprin Isoform-Specific
To confirm that degradation of OS9 was meprin-specific, purified OS9 was co-incubated
with activated meprin B as described above. Controls reactions were included with the
following; (1) activated meprins that were pre-incubated with known meprin inhibitors (EDTA
and actinonin) for 1 hour, (2) latent forms of meprin B, and (3) trypsin-treated buffer. The
reactions were incubated at 37oC for 1 hour and the proteins separated by electrophoresis and
detected by Western blot analysis.

4.1 Cellular Localization of Meprin B and OS9
Western blot analysis showed that mepr
enriched and cytosolic-enriched protein fractions from
This data confirmed that the cells are expressing meprin
cytosolic fraction places meprin in

Figure 1. Evaluation of meprin B expression in meprin
OS9 proteins were most abundant in the nuclear
cell genotypes (non-transfected, meprin
cells. Western blot analysis revealed traced amounts of OS9 within the cytosolic fraction of the
non-transfected cells as seen in Figure
most amount of OS9 from all cell genotypes provided the basis for only using the nuclear
fraction for the protein samples used in all
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Figure 2. Cellular localization of OS9.
4.2 Increase of OS9 in Oxygen--Depleted Non-Transfected HEK293 Cells
With the location of OS9 being established within the cell fraction and the cells
evaluation for the expression of meprin, all genotypes of HEK 293 cells were treated for oxygenoxygen
depletion with the purpose of evaluating the presence of OS9 within the nuclear fraction. OS9
was observed at all time intervals for all of the HEK 293 genotypes. Evaluating the data from
the non-transfected
transfected cells only, OS9 increased over the course of tthe
he treatment. Both the alpha
transfected and beta transfected HEK 293 cells did not change over time (Figure
Figure 3).
3

Figure 3. Increase of OS9 in oxygen
oxygen-depleted non-transfected HEK293 cells.
4.3 Time-Dependent Stabilization
tabilization of HIF1
HIF1α in Oxygen-Depleted HEK293 Cells
C
In addition to performing Western blots of OS9 in oxygen
oxygen-depleted
depleted cells, nuclear levels
of the hypoxia response gene HIF
HIF-1α were also evaluated. As shown in Figure 4, no HIF-1α was
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observed at the zero hour time point with HIF
HIF-1α having
aving trace amounts after 1 hour of oxygenoxygen
depletion. A significant amount of HIF
HIF-1α was detected after 2 and 3 hours of oxygen-depletion
oxygen
for all of the nuclear extracts. It was determined that HIF
HIF-1α stabilized in a time-dependent
time
manner. When comparingg the amount of HIF
HIF-1α detected in the non-transfected
transfected control cells to
the meprin β transfected cells, much more HIF
HIF-1α was detected in the transfected cells with the
most HIF-1α occurring in the beta
beta-transfected cells (Figure 4).

Figure 4. Time-dependent
dependent stabilization of HIF
HIF-1α in oxygen-depleted
depleted HEK293 cells.
These results were obtained from two independent experiments different times. Faint
bands for HIF-1α were observed at zero hours on one occurrence. It was expected that HIF-1α
HIF
may or may not be detected at the time point of 0 hour due to degradation of HIF-1α
HIF
in a
normoxic state.
4.4 Interaction Between
etween OS9 and HIF1
HIF1α in Hypoxia
Combining the data obtained from the Western blots performed on nuclear fractions
frac
of
HEK293 cells depleted of oxygen, a correlation between OS9 and HIF1
HIF1α was suggested.
suggested A
time-dependent
dependent stabilization of HIF1
HIF1α occurred within the nuclear fractions for all 3 genotypes.
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An increase in OS9 was only observed in the non
non-transfected cells.
lls. A relationship appears to
exist between OS9 and HIF1α
α as a response to hypoxia.
4.5 Evaluation of HIF1α in
n ATP
ATP-Depleted MDCK Verses MDCK Beta Transfected
ransfected Cells
Non-transfected
transfected MDCK and MDCK cell transfected with meprin β cDNA were depleted
of ATP using pharmacological
logical agents for 0, 0.5, 1, 2, and 3 hours.. It was observed in both
genotypes that HIF-1α stabilized over time when deprived of ATP (Fig
(Figure 5).

Figure 5. Evaluation of HIF-1α
α in ATP
ATP-depleted
depleted MDCK verses MDCK beta transfected cells.
4.6 Meprin B Degradation
egradation of OS9
In order to determine if meprin cleaves OS9, homomeric active forms of meprin A and B
were incubated with purified recombinant human OS9 for O hr, 0.25 hr, 0.5 hr, 1 hr, 2 hr, and 4
hours. A buffer containing no meprin served as a control. The samples were subjected to
electrophoresis,, and a Western blot was performed to detect OS9 using anti-OS9
OS9 antibodies.
Intense bands of OS9 were observed for the samples prepared with the control buffer (no
meprin) and for the samples
les containing meprin A at all time points. For the reactions containing
meprin B, the intensity of the OS9 band greatly decreased after 30 minutes of co-incubation
co
resulting in an extremely faint OS9 band at 1 hr. No OS9 was detected at the time points of
o 2
and 4 hours. This demonstrates that OS9 is being degraded by meprin B. Figure 6 displays the
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results for no meprin, meprin A, and meprin B incubation with purified OS9. OS9 was detected
amongst all the samples
les containing no meprin (Fig
(Figure 6). The samples
amples incubated with meprin B
revealed one intense band for OS9 at O hour, and no bands were observed for any of
o the other
time points. This data suggests that meprin B degrades OS9.

Figure 6. Meprin B cleaves/degrades
egrades purified OS9.
4.7 Meprin B Degradation
egradation of OS9 Is Meprin Specific.
The specificity of meprin cleaving OS9 was evaluated by incubating purified
recombinant human OS9 with activated meprins, latent forms of meprins, buffer containing no
meprin, and buffers containing meprin inhibitor
inhibitors.
s. The samples were run out on a gel, and a
Western blot for OS9 was performed. Intense bands for OS9 were detected in the samples
containing OS9 with meprin-free
free buffer, OS9 with the latent form of meprin, and OS9 with the
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inhibitor of EDTA. Extremely faint bands were detected in the samples containing OS9 with the
activated form of meprin A, and OS9 with the inhibitor actinonin. The data supports that the
activated forms of meprin degrades OS9 resulting in the observation of no bands, and
demonstratingg that meprin B degradation of OS9 is meprin specific (Figure 7).

Figure 7. Meprin B degradation of OS9 is meprin specific.
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CHAPTER 5
Discussion and Conclusion
Ischemia-reperfusion injury is the leading cause of acute kidney disease (Gunaratnam &
Bonventre, 2009). On average, 2.5% of hospitalized patients will die from complications
resulting from ischemic acute tubular necrosis (Ympa et al., 2005). It is necessary to determine
what is causing the damage inside the organ when normal blood flow is restored after a period of
ischemia and hypoxia. Meprins constitute 5% of the total amount of proteins found in the
kidneys’ brush-border membrane, and meprins have been associated in the pathology of
ischemia-reperfusion induced kidney failure. It has been shown in mice that lower levels of
meprin and no meprin (knockout) lead to less renal injury after ischemia/reperfusion. This
research provided another link in the mechanism for how meprins enhance damage to ischemiareperfusion injured kidney.
An interaction between OS9 and meprin B has previously been described by Litovchick
et al. (2002) suggesting that OS9 may be involved in ER to Golgi transport of meprin B. A gap
was created when OS9 has never been identified as a meprin substrate. The goal of this study
was to determine if OS9 is a meprin substrate. The identity of a meprin substrate will provide to
a better understanding of how meprins are enhancing damage to the kidneys after an episode of
ischemia-reperfusion injury; thus, yielding to developments in the prevention and treatment of
kidney damage resulting from ischemia-reperfusion injury.
To test if OS9 is a meprin substrate, purified human OS9 was co-incubated with meprin
A, meprin B, or no meprin. Results revealed that only meprin B degrades OS9. When the
experiment was repeated using less sample, no OS9 was observed at any time points after 0 hour.
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This suggests that not only is OS9 being degraded by meprin B, but it is also fast acting. An
enzyme has more potential to create damage when the rate of reaction is rapid.
The degradation of OS9 by meprin was further investigated using various experimental
variables to determine the specificity of meprin degradation of OS9. OS9 was incubated with
activated and latent isoforms of meprin, and with known meprin inhibitors. It was determined
that the degradation of OS9 is specific to activated meprin B. This research is the first to identify
OS9 as a meprin substrate, and that degradation only occurs by meprin B.
Meprins relocalize from the brush-border membrane to the cytosol after ischemiareperfusion. It was confirmed by Western blot that meprin is found within the cytosolic fraction.
Meprin being found within the cytosol puts the meprin in close proximity to OS9 located on the
cytoplasmic side of the ER. If meprin was not found within the cytosol, the potential would not
exist for OS9 and meprin to interact with one another.
OS9 is associated with the ER-associated degradation (ERAD) pathway
machinery and ERAD substrates. Misfolded proteins are recognized by the ERAD pathway, and
retranslocated back across the ER membrane in order to be degraded by the cytosolic
proteasome. OS9 binds to the misfolded polypeptide within the lumen of the ER before
transferring the protein to the HRD1 ubiquitin ligase complex transfer and polyubiquitination.
OS9 degradation by meprin B would inhibit the ERAD pathway from occurring. With the
ERAD unable to eliminate misfolded proteins, the proteins would begin to build up within the
cell. The accumulation of protein within the fragile cell could lead to additional damage. Higher
levels of peptides are observed in patients with chronic renal failure when their kidneys are
unable to provide clearance. Data from the current study suggests that the mechanism of damage
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resulting to the kidney upon ischemia-reperfusion is in part the result of the trafficking of
proteins being halted when meprin B degrades OS9.
The second objective of this study was to determine whether OS9 interacts with meprins
and HIF1α under hypoxic conditions. To date, there is no known correlation existing between
OS9 and HIF1α. Hypoxia occurs as a result of ischemia. A cell responds to the low oxygen
level via inducing hypoxia inducible factors with HIF1 functioning as the master regulator of
oxygen homeostasis. Beak et al. (2005) demonstrated that OS9 interacts with HIF1α and HIF1α
prolyl hydroxylases acting as a negative regulator of HIF1 in oxygen homeostasis. Using RNAi,
Beak et al. discovered OS9’s gain-of-function to include HIF1α hydroxylation, HIF1α
proteasomal degradation, and HIF1-mediated degradation. OS9 loss-of-function included
increase levels of HIF1α, and HIF1-mediated transcription. Taking this into consideration, an
increased amount of HIF1α would be expected in cells depleted of oxygen and exposed to
meprins. The results obtained from this study found that HIF1α stabilizes in a time-dependent
course when cells are depleted of oxygen. This is the first time that HIF1α is evaluated in cells
transfected with meprin. An increase in HIF1α was observed in the alpha transfected cells
compared to the non-transfected cells. The biggest increase in the amount of HIF1α was
detected among the beta transfected cells. This would be expected if OS9 is being degraded by
meprin B. The degraded OS9 is no longer able to interact with HIF1α and HIF1α prolyl
hydroxylases to promote degradation of HIF1α. The extra accumulation of HIF1α protein could
potentially result in additional damage to the cell.
In conclusion, this research established that OS9 is a meprin B substrate. Meprin A did
not cleave or degrade OS9 suggesting isoform-specific substrate preference. HIF1α was shown
to be affected by the degradation of OS9 by meprin B; thus, impacting the hypoxia response of
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the cell. It was proposed that cell damage observed in ischemia-reperfusion injury may be
partially the result of the ERAD pathway being modulated when OS9 is degraded by meprin B.
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CHAPTER 6
Future Research
The next step to be performed to continue working on this project is concluding the ATPdepletion experiments in the HEK293 cells. Preliminary data using MDCK cells were obtained,
but due to time restraints, ATP-depletion portion of this project is not complete. The protocol
had to be modified due to cells being lost upon extraction. The new protocol for extracting cells
has been proven to be successful, and is ready to be carried out. Three Western blots each for
OS9 and HIF1α will provide statistically sound data that will be ready to publish. Also, the data
obtained from in vitro results can be combined and compared to in vivo results from the mice
studies.
Immunohistochemistry for OS9 and HIF1α in the HEK293 cells depleted of oxygen and
ATP would be the last component of this project. The visualization would provide direct
evidence to what is occurring to OS9 and HIF1α within the cell. Additionally, a commercially
available ERAD pathway inhibitor could be purchased to compare non-transfected cells to
meprin β transfected cells. The meprin B degradation resulting in the stop of protein trafficking
in the ERAD pathway should result in the same findings where compared to an ERAD pathway
inhibitor in the non-transfected cells. Immunohistochemistry would serve purposely for ERAD
pathway as well.
In the near future, a large scale search for additional meprin substrates can be performed
using techniques such as microarrays and mass spectrometry. The ultimate goal is to not treat
kidney disease, but to prevent damage and disease. The identification of meprin substrates will
aide in drug development. Meprin inhibitors such as actinonin are now available, but they are
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not meprin specific. The identification of all meprin substrates would lead to better drugs that
could be used in personalized medicine.
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